Table 2 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
收藏数据链接：
官方服务：
资源简介：
Treatment-related AEs reported in >2 patients treated with GEN1046 (n = 61)
创建时间：
2022-05-02
